comparemela.com
Home
Live Updates
Kathleen Bloch - Breaking News
Pages:
13
14
15
16
17
18
19
Page 12 - Kathleen Bloch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2022 Results - Earnings Call Transcript
Cytosorbents Corporation (NASDAQ:NASDAQ:CTSO) Q1 2022 Earnings Conference Call May 03, 2022 04:30 PM ET Company Participants Terri Anne Powers - Vice President, Investor Relations &.
United kingdom
City of
United states
New jersey
Priya sachdeva
Jiny kim
Cytosorbents europe
Asklepios kliniken gmb
Shaun whittemore
Kathy bloch
Makis deliargyris
Christian steiner
Chris cramer
Phillip chan
Justin walsh
Christopher cramer
CytoSorbents Receives Approximately $740,000 from the New Jersey Business Tax Certificate Transfer Program
MONMOUTH JUNCTION, N.J., April 7, 2022 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening cond.
United states
New jersey
Monmouth junction
State of new jersey
Eric kim
Kathleen bloch
Material command
Development tax credits rd
Technology business tax certificate transfer program
Jersey division of taxation
Jersey economic development authority
European union
Us army
Blood institute
National heart
Cytosorbents corporation
CytoSorbents receives $740K from tax program
CytoSorbents received approximately $740,000, net of transactions costs, in cash proceeds from the sale of its 2020 NOL and R&D credits.
United states
New jersey
Monmouth junction
Kathleen bloch
Jersey economic development authority
Cytosorbents corp
Technology business tax certificate transfer program
New jersey economic development
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
New jersey
United states
Bentracimab phasebio
Astra zeneca
Eric kim
Phillip chan
Kathleen bloch
Material command
Boehringer ingelheim
Centers for medicare
European union
Us army
Bristol myers squibb
Medicaid services
Cytosorbents corporation
National heart
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
MONMOUTH JUNCTION, N.J., Jan. 18, 2022 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening cond.
New jersey
United states
Monmouth junction
Bentracimab phasebio
Astra zeneca
Eric kim
Phillip chan
Kathleen bloch
Material command
Boehringer ingelheim
Centers for medicare
European union
Us army
Bristol myers squibb
Medicaid services
Cytosorbents corporation
vimarsana © 2020. All Rights Reserved.